Author: admin

SAN DIEGO, Dec. 26, 2024 /PRNewswire/ — Robbins LLP reminds investors that a shareholder filed a class action against Kyverna Therapeutics, Inc. (NASDAQ: KYTX) and certain of the Company’s senior executives and directors who signed the Registration Statement, effective February 7, 2024,

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: